Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Metabotropic glutamate receptor 5 (mGluR5) is a G protein-coupled receptor. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol calcium second messenger system and generates a calcium activated chloride current.
The Metabotropic Glutamate Receptor 5 pipeline drugs market research report provides comprehensive information on the therapeutics under development for Metabotropic Glutamate Receptor 5, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key players involved in therapeutic development for Metabotropic Glutamate Receptor 5 and features dormant and discontinued projects.
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Segmentation by Therapy Areas
The key therapy areas in the Metabotropic Glutamate Receptor 5 pipeline products market are Central Nervous System, Genetic Disorders, Ophthalmology, and Undisclosed.
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Analysis, by Therapy areas
For more target insights into the Metabotropic Glutamate Receptor 5 pipeline drugs market, download a free report sample
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Segmentation by Mechanism of Actions
The key mechanisms of action in the Metabotropic Glutamate Receptor 5 pipeline products market are Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 5 Agonist.
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Analysis, by Mechanisms of Action
For more mechanisms of action insights into the Metabotropic Glutamate Receptor 5 pipeline drugs market, download a free report sample
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Segmentation by Routes of Administration
The key route of administration in the Metabotropic Glutamate Receptor 5 pipeline products market is oral.
Metabotropic Glutamate Receptor Pipeline Drugs Market Segmentation by Molecule Types
The different molecule type in the Metabotropic Glutamate Receptor 5 pipeline products market is small molecule and peptide.
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Analysis, by Molecule Types
For more molecule type insights into the Metabotropic Glutamate Receptor 5 pipeline drugs market, download a free report sample
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market - Competitive Landscape
The major companies in the Metabotropic Glutamate Receptor 5 pipeline products market are Addex Therapeutics Ltd, Allyx Therapeutics Inc, Appello Pharmaceuticals Inc, Bristol-Myers Squibb Co, Hua Medicine Shanghai Ltd, Laboratorio Farmaceutico CT Srl, and Lactocore Inc among others.
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Analysis, by Companies
To know more about the companies in the Metabotropic Glutamate Receptor 5 pipeline drugs market, download a free report sample
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Report Overview
| Key Therapy Areas | Central Nervous System, Genetic Disorders, and Undisclosed |
| Key Mechanism of Actions | Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 5 Agonist |
| Key Routes of Administration | Oral |
| Key Molecule Types | Small Molecule, and Peptide |
| Leading Companies | Addex Therapeutics Ltd, Allyx Therapeutics Inc, Appello Pharmaceuticals Inc, Bristol-Myers Squibb Co, Hua Medicine Shanghai Ltd, Laboratorio Farmaceutico CT Srl, and Lactocore Inc |
Segments Covered in the Report
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Therapy Areas Outlook
- Central Nervous System
- Genetic Disorders
- Undisclosed
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Mechanism of Actions Outlook
- Metabotropic Glutamate Receptor 5 Antagonist
- Metabotropic Glutamate Receptor 5 Agonist
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Routes of Administration Outlook
- Oral
Metabotropic Glutamate Receptor 5 Pipeline Drugs Market Molecule Types Outlook
- Small Molecule
- Peptide
Scope
- The report provides a snapshot of the global therapeutic landscape for Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5)
- The report reviews Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics and enlists all their major and minor projects
- The report assesses Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5)Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Allyx Therapeutics Inc
Appello Pharmaceuticals Inc
Bristol-Myers Squibb Co
Hua Medicine Shanghai Ltd
Laboratorio Farmaceutico CT Srl
Lactocore Inc
Nobias Therapeutics Inc
Noema Pharma AG
Novartis AG
Park of Active Molecules
Tempero Bio
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the Metabotropic Glutamate Receptor 5 pipeline drugs market?
The key therapy areas of the Metabotropic Glutamate Receptor 5 pipeline drugs market are Central Nervous System, Genetic Disorders, Ophthalmology, and Undisclosed.
-
What are the key mechanism of actions of the Metabotropic Glutamate Receptor 5 pipeline drugs market?
The key mechanism of action of the Metabotropic Glutamate Receptor 5 pipeline drugs market are Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 5 Agonist.
-
What are the key routes of administration in the Metabotropic Glutamate Receptor 5 pipeline drugs market?
The key route of administration in the Metabotropic Glutamate Receptor 5 pipeline drugs market is Oral.
-
What are the key molecule types in the Metabotropic Glutamate Receptor 5 pipeline drugs market?
The molecule types in the Metabotropic Glutamate Receptor 5 pipeline drugs market are small molecule and peptide.
-
Which are the leading companies in the Metabotropic Glutamate Receptor 5 pipeline drugs market?
Some of the leading companies in the Metabotropic Glutamate Receptor 5 pipeline drugs market are Addex Therapeutics Ltd, Allyx Therapeutics Inc, Appello Pharmaceuticals Inc, Bristol-Myers Squibb Co, Hua Medicine Shanghai Ltd, Laboratorio Farmaceutico CT Srl, and Lactocore Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Other Diseases reports